Navigation Links
Boehringer Ingelheim's Jeff Huth Elected as National Pharmaceutical Council's Chairman of the Board
Date:11/8/2013

WASHINGTON, Nov. 8, 2013 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Jeff Huth, Senior Vice President, Managed Markets, Boehringer Ingelheim Pharmaceuticals Inc. (BI), has been elected chairman of its Board of Directors for 2013-14. Mr. Huth has served on NPC's Board since 2009 and has previously held the positions of vice chair and treasurer.

(Photo:  http://photos.prnewswire.com/prnh/20131108/DC13524)

"Throughout his tenure on our board, Jeff has been dedicated to promoting NPC and its role as a leading health care policy research organization," said NPC President Dan Leonard. "We're looking forward to having Jeff play an even more active role in leading NPC's efforts on issues related to balancing the needs of patients with the population, the value of pharmaceuticals, and the use of real-world evidence."

Mr. Huth has more than 30 years of experience in the pharmaceutical industry, where he has served in a wide spectrum of roles ranging from pre-clinical development to marketing and sales management.  His career with Boehringer Ingelheim has included international assignments at BI's affiliate in the United Kingdom and at corporate headquarters in Germany. Upon returning to the U.S., he assumed responsibility for marketing and in 2009 moved to his current position, for which he is responsible for pricing and contracting, trade relations, health economics and leading field-based teams interacting with customers in the private and government payer channels. In the U.S., BI develops and markets therapies in the respiratory, cardiovascular, metabolic, anti-viral and oncology areas.

The NPC Board also elected Anne Whitaker, President, North America Pharmaceuticals, Sanofi, as Vice Chair; David Martin, Vice President, Managed Markets, Value & Access Group, Eisai Inc. as Treasurer; and Giovanni Caforio, MD, President, U.S. Pharmaceuticals, Bristol-Myers Squibb Company, and Steven Romano, MD, Senior Vice President, Head, Medicines Development Group, Pfizer Inc, to serve on the executive committee.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow. 


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Boehringer Ingelheims interferon-free hepatitis C treatment portfolio strengthened by promising interim Phase 2a data
2. Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
3. Boehringer Ingelheim Pharmaceuticals, Inc. colabora con Univision Communications Inc. para lanzar una campaña integrada en español
4. Boehringer Ingelheim Pharmaceuticals, Inc. Collaborates With Univision Communications Inc. To Launch An Integrated Campaign In Spanish
5. Boehringer Ingelheims investigational volasertib receives FDA Breakthrough Therapy designation
6. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
7. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
8. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
9. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
10. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
11. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2017)... 11, 2017  Thornhill Research Inc. ( ... an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by ... Commercial Corporation (CCC) ( Ottawa, Ontario, Canada ... administer general anesthesia to patients requiring emergency medical ... US Marine Corps have been a longtime partner ...
(Date:5/10/2017)... 10, 2017 Global Health Intelligence (GHI), ... America , published its 2017 ranking of the ... on extensive data analysis from GHI,s hospitals database for ... for the region. The GHI database covers 86% of the ... than 130 data points for each institution in key areas ...
(Date:5/10/2017)... May 10, 2017 Radiology has become the ... costs have also spiraled to the number one ranking ... radiology than ever before as the most complete and ... patient with lower back pain an MRI may confirm ... for pain, resulting in entirely different treatment protocols.  In ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... is focusing on the Peace Agreements being discussed by President Donald Trump and the ... race to try to speed up peace talks in the continuous battle between Israel ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: ... the creation of published author Laura Weigel Douglas, an avid reader who lives in ... house that sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “Cactus Jack: ... had on so many others. “Cactus Jack: Against All Odds” is the creation ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. ...
(Date:5/24/2017)... ... 2017 , ... Dr. Alan I. Benvenisty, MD is dual board certified in ... known for his distinguished expertise and experience in the diagnosis and treatment of vascular ... treating renovascular disease and aortic aneurysm . He is known for his minimally ...
Breaking Medicine News(10 mins):